Atlas FDA

BOSTON EQUALENS (ITAFLUOROFOCON A AND OPRIFOCON A)

FDA premarket approval P860022/S056 · decided 2006-05-30

Approval details

PMA number
P860022
Supplement
S056
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
BOSTON EQUALENS (ITAFLUOROFOCON A AND OPRIFOCON A)
Generic name
Lens, contact (rigid gas permeable), extended wear
Applicant
Bausch & Lomb
Date received
2006-01-27
Decision date
2006-05-30
Days to decision
123 days
Decision code
APPR
Product code
MWL
Advisory committee
Ophthalmic
Expedited review
No
Location
Rochester, NY
Statement
APPROVAL FOR THE ADDITION OF A COLD OXYGEN PLASMA TREATMENT STEP TO THE CURRENT MANUFACTURING PROCESS FOR THE BOSTON EQUALENS (ITAFLUOROFOCON A), BOSTON EQUALENS II, AND BOSTON ORTHOKERATOLOGY (OPRIFOCON A) SHAPING LENS

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Stellaris Elite vision enhancement system (K170052)Bausch+Lomb2017-04-19
Stellaris Elite Vision Enhancement System (K162342)Bausch+Lomb2017-03-24
STELLARIS PC VISION ENHANCEMENT SYSTEM (K133486)Bausch & Lomb2014-03-12
STELLARIS VISION ENHANCEMENT SYSTEM (K133242)Bausch & Lomb2014-02-14
BAUSCH & LOMB INJECTOR SYSTEM (K131958)Bausch & Lomb2014-01-09
BAUSCH + LUMB, VIS100 INJECTOR SYSTEM (K133146)Bausch & Lomb2014-01-03
EASY-LOAD LENS DELIVERY SYSTEM (K132481)Bausch & Lomb2013-12-27
CRYSTALSERT DELIVERY SYSTEM (K132593)Bausch & Lomb2013-09-17